Artios Pharma
UK - Cambridge
PharmaceuticalFocus: DNA Damage Response Therapies
Artios Pharma is a life sciences company focused on DNA Damage Response Therapies.
Oncology
Funding Stage
PUBLIC
Open Jobs
0
Pipeline & Clinical Trials
Determination of ATM alteration status.
Solid Tumor, Unspecified, AdultClinical Trials (1)
NCT04976803Tissue Collection for Correlation Between ATM Alterations by Next-Generation Sequencing and ATM Loss-of-Protein
N/AART4215
Advanced CancerClinical Trials (1)
NCT04991480A Study of ART4215 for the Treatment of Advanced or Metastatic Solid Tumors
Phase 1ART0380
Advanced CancerClinical Trials (1)
NCT04657068A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Phase 1/2ART6043
Advanced Solid TumorClinical Trials (1)
NCT05898399Study of ART6043 in Advanced/Metastatic Solid Tumors Patients
Phase 1/2ART0380
Advanced Solid TumorClinical Trials (1)
NCT05798611Study of ART0380 in Patients With Biologically Selected Solid Tumors
Phase 2Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Founded: 2024
Portfolio: 5 clinical trials